课题基金 / 基金详情

Molecule gene analysis of bone absorption in bone reproduction medical care and development of bone absorption restraint medicine

Molecule gene analysis of bone absorption in bone reproduction medical care and development of bone absorption restraint medicine
骨再生医疗中骨吸收的分子基因分析及骨吸收抑制药物的开发
批准号:
15390614
负责人:
SUGAHARA Toshio
金额:
$9.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

SUGAHARA Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
肌肉注射(1 mg/kg)免疫抑制剂FK 506至裸鼠和T细胞连续28天遭受损失的野生型小鼠,并制作骨质疏松模型小鼠,以通过免疫抑制剂寻找细胞促免疫性和与骨质疏松症发病的相关性。结果,对于FK 506实验组的骨吸收,野生型比软骨内骨化更能识别骨小梁的减少,而对于阳性破骨细胞,TRAP染色的软骨内骨化的数量增加再次比对照组更明显。然而,对于下部的骨吸收,对于免疫抑制剂引起的骨质疏松症,由于没有控制和变化,除了用裸鼠进行的软骨内骨化外,还暗示了免疫系统细胞如T细胞的相关性。 ...更多信息 n产品(PC),这是一个瑞士奶酪的启动器,以这种骨质疏松症模型。我们这次检查了该发酵产物的骨吸收抑制效果。当我通过FK 506给骨质疏松症小鼠施用丙酸菌发酵产物(PC)时,我能够阻止骨吸收。近年来,许多现有的DHNA具有与维生素K2相同的萘醌框架,在PC内具有一定量的骨改善作用的骨盐物质中引起注意。我注意到这一点,当我们单独给予DHNA时,我们接受了与骨质疏松模型PC相同的骨吸收抑制。至于DHNA,PC的骨吸收抑制作用能够通过DHNA从PC中大量包含的物质中识别出。当我在小鼠的破骨细胞中加入作为T细胞的B细胞和作为骨髓中四扭CD阳性的B220阳性,即体外的骨芽细胞时,我将破骨细胞与对照进行了比较。如磁珠作用下的打击罗马细胞和骨髓细胞明显增加。少
英文摘要
Intramuscular injection (1 mg/kg) did immunity restraint agent FK506 to a nude mouse and a mouse of a wild type that a T cell suffered a loss day after day on 28th and made an osteoporosis model mouse to search a cell pro-immunity and relevance with the onset of osteoporosis by immunity restraint agent. As a result, as for the bone absorption of a group of experiments by FK506, decrease of trabecula bone was recognized by a wild type more underneath than enchondral ossification, and, as for positive osteoclast, numbers increased in enchondral ossification for TRAP dyeing more clearly than a group of control again. However, as for the bone absorption in the lower part, as for the osteoporosis by immunity restraint agent, what an immunity system cell such as a T cell was related to was suggested without most than enchondral ossification with a nude mouse by there not being control and a change.I discovered that osteoporosis recovered when we administered Propion acid bacteria fermentatio … More n product (PC) that was a starter of Swiss cheese to this osteoporosis model. We examined a bone absorption restraint effect from this fermentation product this time. I was able to prevent the bone absorption when I administered Propion acid bacteria fermentation product (PC) to an osteoporosis mouse by FK506.In late years a lot of existing DHNA has a naphthoquinone frame the same as vitamins K2 attracting attention in a quantity of bone salt thing having quantity of bone improvement action within a PC.I paid attention to this point, and we accepted bone absorption restraint same as a PC for an osteoporosis model when we administered DHNA alone. As for DHNA, the bone absorption restraint effect of a PC was able to identify a thing by DHNA from what was included in a PC abundantly.I compared osteoclast with control when I added the B cell which was a T cell and the B220 positive that were four twist CD positive in marrow in osteoclast of a mouse namely in vitro of bone bud cell-like strike Rome cell and marrow cell with magnetic beads and increased significantly. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Vascular Endothelial Growth Factor(VEGF) and Bone Morphogenetic Protein-4(BMP-4) in Endochondra Ossification from Grafted Periosteum
血管内皮生长因子(VEGF)和骨形态发生蛋白-4(BMP-4)在移植骨膜软骨内骨化中的作用
DOI: --
发表时间: 2003
期刊: Acta Histochemistry Gytochemistry 36(1)
影响因子: --
作者: [Toshio Sugahara, Takaaki Ueno et al.]
通讯作者: Takaaki Ueno et al.
骨粗鬆癌学-基礎・臨床研究の新しいパラダイム 免疫抑制剤が引き起こす骨粗鬆症
骨质疏松症肿瘤学 - 基础和临床研究的新范式 免疫抑制剂引起的骨质疏松症
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [菅原利夫, 福永城司]
通讯作者: 福永城司
Toshio Sugahara, Takaaki Ueno et al.: "Vascular Endothelial Growth Factor(VEGF)and Bone Morphogenetic Protein-4(BMP-4) in Endochondra Ossification from Grafted Periosteum"Acta Histochemistry Cytochemistry. 36(1). 61-66 (2003)
Toshio Sugahara、Takaaki Ueno 等人:“血管内皮生长因子 (VEGF) 和骨形态发生蛋白 4 (BMP-4) 在移植骨膜内软骨骨化中的作用”组织化学细胞化学学报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Vascular Endothelial Growth Factor (VEGF) and Bone Morphogenetic Protein-4 (BMP-4) in Endochondra Ossification from Grafted Periosteum
血管内皮生长因子 (VEGF) 和骨形态发生蛋白 4 (BMP-4) 在移植骨膜软骨内骨化中的作用
DOI: --
发表时间: 2003
期刊: Acta Histochemistry Cytochemistry 36(1)
影响因子: --
作者: [Toshio Sugahara, Takaaki Ueno et al.]
通讯作者: Takaaki Ueno et al.
共 20 条
    Research on metabolic mechanism of palatal processes and cleft palate onset mechanism from genes
    • 批准号:
      16K11772
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      SUGAHARA Toshio
    • 依托单位:
    Localization of Perlecan and Heparanase in the Epithelial
    • 批准号:
      22592269
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      SUGAHARA Toshio
    • 依托单位:
    The study of molecular and gene analysis and bone metabolism-improving effect of propiomibacterium freudenreichii milk whey culture against osteoporosis.
    • 批准号:
      17390538
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.05万
    • 财政年份:
      2005
    • 负责人:
      SUGAHARA Toshio
    • 依托单位:
    国内基金
    海外基金
    新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
    • 批准号:
      82370885
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      姚晨
    • 依托单位:
    Pre-osteoclast调控的血管-骨形成偶联在骨性关节炎发病进展中的机制研究
    • 批准号:
      81601942
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2016
    • 负责人:
      崔壮
    • 依托单位:
    一个潜在的、防治骨质破坏的药物靶点的新发现
    • 批准号:
      30670997
    • 项目类别:
      面上项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2006
    • 负责人:
      许多荣
    • 依托单位: